07Jan
DEAL WATCH: End-of-Year Biosimilar Agreements
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By:
Goodwin
Related
Our team of M&A and project finance partners will discuss some key tips in maximizing efficiency in ...
Read More >
On Wednesday, May 27, 2020, the Internal Revenue Service (“IRS”) issued a notice to extend the con...
Read More >
California Governor Gavin Newsom signed into law Assembly Bill 5 (“AB-5”). AB-5 codifies into Cali...
Read More >
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the ...
Read More >
El 31 de julio de 2019, se publicó en el Diario Oficial de la Federación el Protocolo para la Legiti...
Read More >
• Following the financial crisis, nonbank lenders looking to carve out new, profitable niches—espe...
Read More >